Medical News

(Dana-Farber Cancer Institute) The novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination shows promise of improved outcomes, sa...

This year, scientists made strides in using stem cells in treatments for human brains, livers, and hearts.

(Dana-Farber Cancer Institute) A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 cli...